The FDA approved the Tecnis Synergy and Tecnis Synergy Toric II IOLs for patients with cataracts, according to a press release from Johnson & Johnson Vision.
The company said the presbyopia-correcting IOLs provide better contrast, particularly in low-light environments, and in a company-sponsored study, nine out of 10 patients did not need glasses after surgery.
“The Tecnis Synergy IOL combines the best of extended depth of focus and multifocal technologies to deliver the widest range of continuous vision with the best near vision among leading [presbyopia-correcting] IOLs, without